Pfizer Inc. (PFE) Tops Q1 EPS by 1c; Reaffirms Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.66 +0.07%
Revenue Growth %: -4.6%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -4.6%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Pfizer Inc. (NYSE: PFE) reported Q1 EPS of $0.60, $0.01 better than the analyst estimate of $0.59. Revenue for the quarter came in at $16.5 billion versus the consensus estimate of $16.65 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Truist sees this stock unfairly punished in data center infrastructure sell-off
- CoreWeave Added Over $25B Net New Customer Commitments Early In 3Q
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
